Myotrophin: Starting Phase II/III trial

Cephalon Inc. (CEPH) Product: Myotrophin, insulin-like growth factor 1 Indication: Amyotrophic lateral sclerosis Status: Starting Phase II/III trial in 150 patients in Europe, with a three-month evalu...